These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17067535)

  • 1. [Onycholysis with hyponychium exudate secondary to chemotherapy with paclitaxel and capecitabine].
    Tejera A; Bosch RJ; López N; Herrera E
    Actas Dermosifiliogr; 2006 Oct; 97(8):536-8. PubMed ID: 17067535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A GINECO randomized phase II trial of two capecitabine and weekly paclitaxel schedules in metastatic breast cancer.
    Lortholary A; Hardy-Bessard AC; Bachelot T; de Rauglaudre G; Alexandre J; Bourgeois H; Jaubert D; Paraiso D; Largillier R
    Breast Cancer Res Treat; 2012 Jan; 131(1):127-35. PubMed ID: 21947680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of capecitabine and weekly paclitaxel in patients with metastatic breast cancer previously treated with every-3-week taxane therapy.
    Blum JL; Dees EC; Vukelja SJ; Amare M; Gill DP; McMahon RT; Ilegbodu D; Asmar L; O'Shaughnessy JA
    Clin Breast Cancer; 2007 Feb; 7(6):465-70. PubMed ID: 17386123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Onycholysis with the appearance of a "sunset" secondary to capecitabine.
    Maino KL; Norwood C; Stashower ME
    Cutis; 2003 Sep; 72(3):234-6. PubMed ID: 14533836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer: single agents chemotherapy.
    Monfardini S; Beda M; Fratino L
    Tumori; 2002; 88(1 Suppl 1):S55-6. PubMed ID: 11989925
    [No Abstract]   [Full Text] [Related]  

  • 6. Randomised, phase II trial comparing oral capecitabine (Xeloda) with paclitaxel in patients with metastatic/advanced breast cancer pretreated with anthracyclines.
    Talbot DC; Moiseyenko V; Van Belle S; O'Reilly SM; Alba Conejo E; Ackland S; Eisenberg P; Melnychuk D; Pienkowski T; Burger HU; Laws S; Osterwalder B
    Br J Cancer; 2002 May; 86(9):1367-72. PubMed ID: 11986765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Final results of a phase II clinical trial of weekly docetaxel in combination with capecitabine in anthracycline-pretreated metastatic breast cancer.
    Mackey JR; Tonkin KS; Koski SL; Scarfe AG; Smylie MG; Joy AA; Au HJ; Bodnar DM; Soulieres D; Smith SW
    Clin Breast Cancer; 2004 Oct; 5(4):287-92. PubMed ID: 15507175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exudative hyponychial dermatitis associated with capecitabine and docetaxel combination chemotherapy for metastatic breast carcinoma: report of three cases.
    Chen GY; Chang TW; Chen WC
    Br J Dermatol; 2003 May; 148(5):1071-3. PubMed ID: 12786853
    [No Abstract]   [Full Text] [Related]  

  • 9. Capecitabine with weekly paclitaxel for advanced breast cancer: a phase I dose-finding trial.
    Uhlmann C; Ballabeni P; Rijken N; Brauchli P; Mingrone W; Rauch D; Pestalozzi BC; Rochlitz C; Aebi S; ;
    Oncology; 2004; 67(2):117-22. PubMed ID: 15539915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Onycholysis associated with capecitabine in patients with breast cancer.
    Hogeling M; Howard J; Kanigsberg N; Finkelstein H
    J Cutan Med Surg; 2008; 12(2):93-5. PubMed ID: 18346407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of capecitabine and weekly paclitaxel as first-line therapy for metastatic breast cancer.
    Blum JL; Dees EC; Chacko A; Doane L; Ethirajan S; Hopkins J; McMahon R; Merten S; Negron A; Neubauer M; Ilegbodu D; Boehm KA; Asmar L; O'Shaughnessy JA
    J Clin Oncol; 2006 Sep; 24(27):4384-90. PubMed ID: 16926223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evolving role of capecitabine in breast cancer.
    O'Shaughnessy JA
    Clin Breast Cancer; 2003 Apr; 4 Suppl 1():S20-5. PubMed ID: 12756075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal melanonychia induced by capecitabine.
    Paravar T; Hymes SR
    Dermatol Online J; 2009 Oct; 15(10):11. PubMed ID: 19951629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A comparative randomized phase-II study of Xeloda (capecitabine) and paclitaxel in patients with breast cancer progressing after anthracycline antibiotics].
    Moiseenko VM; O'Reilly SM; Dalbot DC; Van Belle S; Gordon RJ; Griffin T; Osterwalder B
    Vopr Onkol; 2000; 46(3):285-9. PubMed ID: 10976273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nail changes during docetaxel containing combination chemotherapy.
    Woo IS; Shim KH; Kim GY; Lee MA; Kang JH; Hong YS; Lee KS
    Korean J Intern Med; 2004 Jun; 19(2):132-3. PubMed ID: 15366647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nail and periungual toxicity following capecitabine therapy.
    Vaccaro M; Barbuzza O; Guarneri F; Guarneri B
    Br J Clin Pharmacol; 2008 Aug; 66(2):325-6. PubMed ID: 18384441
    [No Abstract]   [Full Text] [Related]  

  • 17. [A case of occult breast cancer successfully treated by capecitabine in combination with weekly paclitaxel followed by FEC (75)].
    Hino N; Ikushima Y; Tsuyuguchi M; Sohnaka Y; Wada D; Yamasaki S; Miyake H; Ogasawara T; Yamamoto Y; Ohura R
    Gan To Kagaku Ryoho; 2008 May; 35(5):809-12. PubMed ID: 18487918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient and practice impact of capecitabine compared to taxanes in first-/second-line chemotherapy for metastatic breast cancer.
    Schwartzberg LS; Cobb P; Walker MS; Stepanski EJ; Houts AC
    Support Care Cancer; 2009 Aug; 17(8):1081-8. PubMed ID: 19148686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capecitabine and paclitaxel combination chemotherapy for inoperable or recurrent breast cancer: a phase I dose-finding study by the Kinki Breast Cancer Study Group.
    Masuda N; Taguchi T; Nakayama T; Shiba E; Watatani M; Kurebayashi J; Takatsuka Y; Sakamoto J; Noguchi S;
    Cancer Chemother Pharmacol; 2008 May; 61(6):989-95. PubMed ID: 17641893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Unilateral acral necrosis as a minor form of hand-foot syndrome. Patient with unilateral acral necrosis secondary to capecitabine therapy for metastatic breast cancer].
    Sauter C; Saborowski A; Ockenfels HM
    Hautarzt; 2007 Jul; 58(7):619-22. PubMed ID: 17066280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.